Newsfeeds - Spark Newswire

3 minute read

Virpax Pharmaceuticals Provides Progress Update On Product Candidates

Today, 3:24 PM

Virpax® Pharmaceuticals Inc. ("Virpax" or the "Company") (NASDAQ:VRPX), today is providing a progress update on its pipeline of product candidates following the Company's initial public

VRPX

2 minute read

20 Stocks Moving in Thursday’s Pre-Market Session

By Lisa Levin

Today, 3:24 PM

Gainers Alterity Therapeutics Ltd (NASDAQ: ATHE) shares rose 64% to $2.14 in pre-market trading. Alterity Therapeutics recently said it received EU regulatory guidance for ATH434 Phase 2 clinical trial.

ADMP

4 minute read

The Daily Biotech Pulse: Gemini Sinks On Data, Amgen’s Migraine Drug Approved In Japan, Liver Congress Gets Underway

By Shanthi Rexaline

Today, 3:24 PM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 22)

ACET

2 minute read

FDA
News

Virpax To Use Envelta IND Enabling Study Results For 2 Additional Indications

By Benzinga Newsdesk

Today, 3:24 PM

Virpax® Pharmaceuticals, Inc. ("Virpax" or the "Company") (NASDAQ:VRPX), today announced that the Investigational New Drug (IND) Application enabling studies for Envelta™ being

VRPX